{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:50:50Z","timestamp":1786467050438,"version":"build-2736575974"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Xinxiang Major Science and Technology Special Project","award":["ZDYF202605"],"award-info":[{"award-number":["ZDYF202605"]}]},{"name":"the Science and Technology Research Project of Henan Province","award":["252102111004"],"award-info":[{"award-number":["252102111004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11262-026-02249-4","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T18:28:03Z","timestamp":1781288883000},"page":"428-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reverse genetics strategies for coronaviruses: platform construction and applications in vaccine development"],"prefix":"10.1007","volume":"62","author":[{"given":"Yuhang","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunzhu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aohan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songbiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"3","key":"2249_CR1","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","volume":"17","author":"J Cui","year":"2019","unstructured":"Cui J, Li F, Shi ZL (2019) Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 17(3):181\u2013192","journal-title":"Nat Rev Microbiol"},{"issue":"1","key":"2249_CR2","doi-asserted-by":"publisher","first-page":"2520335","DOI":"10.1080\/21505594.2025.2520335","volume":"16","author":"C Ma","year":"2025","unstructured":"Ma C, Yang Y, Zu J (2025) Predicting the evolutionary and epidemiological dynamics of SARS-CoV-2 in South Africa. Virulence 16(1):2520335","journal-title":"Virulence"},{"key":"2249_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09340-0","author":"C Attipa","year":"2025","unstructured":"Attipa C, Warr AS, Epaminondas D et al (2025) Feline infectious peritonitis epizootic caused by a recombinant coronavirus. Nat. https:\/\/doi.org\/10.1038\/s41586-025-09340-0","journal-title":"Nat"},{"issue":"1","key":"2249_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s12917-025-05115-x","volume":"21","author":"RM Mumo","year":"2025","unstructured":"Mumo RM, Ribbens S, Gr\u00e9goire F et al (2025) Seroprevalence of coronaviruses of cattle and pigs in Belgian herds. BMC Vet Res 21(1):659","journal-title":"BMC Vet Res"},{"issue":"1","key":"2249_CR5","doi-asserted-by":"publisher","first-page":"2525930","DOI":"10.1080\/21505594.2025.2525930","volume":"16","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Hou R, Wei Z et al (2025) Development of the coronavirus reverse genetic system: core technology for pathogenesis mechanisms research and vaccine\/drug development. Virulence 16(1):2525930","journal-title":"Virulence"},{"key":"2249_CR6","doi-asserted-by":"publisher","first-page":"106122","DOI":"10.1016\/j.tvjl.2024.106122","volume":"305","author":"M Ujike","year":"2024","unstructured":"Ujike M, Suzuki T (2024) Progress of research on coronaviruses and toroviruses in large domestic animals using reverse genetics systems. Vet J 305:106122","journal-title":"Vet J"},{"issue":"6","key":"2249_CR7","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.virs.2023.10.001","volume":"38","author":"HL Cai","year":"2023","unstructured":"Cai HL, Huang YW (2023) Reverse genetics systems for SARS-CoV-2: development and applications. Virol Sin 38(6):837\u2013850","journal-title":"Virol Sin"},{"issue":"5","key":"2249_CR8","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","volume":"27","author":"X Xie","year":"2020","unstructured":"Xie X, Muruato A, Lokugamage KG et al (2020) An infectious cDNA clone of SARS-CoV-2. Cell Host Microbe 27(5):841-848 e3","journal-title":"Cell Host Microbe"},{"key":"2249_CR9","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01628-25","author":"G Guo","year":"2025","unstructured":"Guo G, Zhang M, Xu Z et al (2025) Genome-wide CRISPR screen reveals key role of sialic acids in PEDV and porcine coronavirus infections. MBio. https:\/\/doi.org\/10.1128\/mbio.01628-25","journal-title":"MBio"},{"key":"2249_CR10","doi-asserted-by":"publisher","first-page":"106627","DOI":"10.1016\/j.prevetmed.2025.106627","volume":"244","author":"O Osemeke","year":"2025","unstructured":"Osemeke O, Silva GS, Corzo CA et al (2025) Economic impact of productivity losses attributable to porcine reproductive and respiratory syndrome virus in United States pork production, 2016\u20132020. Prev Vet Med 244:106627","journal-title":"Prev Vet Med"},{"issue":"1","key":"2249_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.virusres.2006.01.017","volume":"117","author":"AE Gorbalenya","year":"2006","unstructured":"Gorbalenya AE, Enjuanes L, Ziebuhr J et al (2006) Nidovirales: evolving the largest RNA virus genome. Virus Res 117(1):17\u201337","journal-title":"Virus Res"},{"issue":"12","key":"2249_CR12","doi-asserted-by":"publisher","first-page":"e1003760","DOI":"10.1371\/journal.ppat.1003760","volume":"9","author":"EC Smith","year":"2013","unstructured":"Smith EC, Denison MR (2013) Coronaviruses as DNA wannabes: a new model for the regulation of RNA virus replication fidelity. PLoS Pathog 9(12):e1003760","journal-title":"PLoS Pathog"},{"issue":"5","key":"2249_CR13","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0022-2836(03)00865-9","volume":"331","author":"EJ Snijder","year":"2003","unstructured":"Snijder EJ, Bredenbeek PJ, Dobbe JC et al (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331(5):991\u20131004","journal-title":"J Mol Biol"},{"issue":"2","key":"2249_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1006\/viro.1994.1053","volume":"198","author":"JC Boyer","year":"1994","unstructured":"Boyer JC, Haenni AL (1994) Infectious transcripts and cDNA clones of RNA viruses. Virol 198(2):415\u2013426","journal-title":"Virol"},{"issue":"22","key":"2249_CR15","doi-asserted-by":"publisher","first-page":"10600","DOI":"10.1128\/JVI.74.22.10600-10611.2000","volume":"74","author":"B Yount","year":"2000","unstructured":"Yount B, Curtis KM, Baric RS (2000) Strategy for systematic assembly of large RNA and DNA genomes: transmissible gastroenteritis virus model. J Virol 74(22):10600\u201310611","journal-title":"J Virol"},{"key":"2249_CR16","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.virusres.2014.05.026","volume":"189","author":"F Almaz\u00e1n","year":"2014","unstructured":"Almaz\u00e1n F, Sola I, Zu\u00f1iga S et al (2014) Coronavirus reverse genetic systems: infectious clones and replicons. Virus Res 189:262\u2013270","journal-title":"Virus Res"},{"issue":"10","key":"2249_CR17","doi-asserted-by":"publisher","first-page":"5516","DOI":"10.1073\/pnas.97.10.5516","volume":"97","author":"F Almaz\u00e1n","year":"2000","unstructured":"Almaz\u00e1n F, Gonz\u00e1lez JM, P\u00e9nzes Z et al (2000) Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. Proc Natl Acad Sci U S A 97(10):5516\u20135521","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2249_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/mBio.00524-13","volume":"4","author":"MM Angelini","year":"2013","unstructured":"Angelini MM, Akhlaghpour M, Neuman BW et al (2013) Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. MBio 4(4):10\u20131128","journal-title":"MBio"},{"issue":"21","key":"2249_CR19","doi-asserted-by":"publisher","first-page":"11065","DOI":"10.1128\/JVI.76.21.11065-11078.2002","volume":"76","author":"B Yount","year":"2002","unstructured":"Yount B, Denison MR, Weiss SR et al (2002) Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J Virol 76(21):11065\u201311078","journal-title":"J Virol"},{"issue":"7813","key":"2249_CR20","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-020-2294-9","volume":"582","author":"T Thi Nhu Thao","year":"2020","unstructured":"Thi Nhu Thao T, Labroussaa F, Ebert N et al (2020) Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nat 582(7813):561\u2013565","journal-title":"Nat"},{"issue":"21","key":"2249_CR21","doi-asserted-by":"publisher","first-page":"10900","DOI":"10.1128\/JVI.00385-06","volume":"80","author":"F Almaz\u00e1n","year":"2006","unstructured":"Almaz\u00e1n F, Dediego ML, Gal\u00e1n C et al (2006) Construction of a severe acute respiratory syndrome coronavirus infectious cDNA clone and a replicon to study coronavirus RNA synthesis. J Virol 80(21):10900\u201310906","journal-title":"J Virol"},{"issue":"8","key":"2249_CR22","doi-asserted-by":"publisher","first-page":"e69997","DOI":"10.1371\/journal.pone.0069997","volume":"8","author":"C Li","year":"2013","unstructured":"Li C, Li Z, Zou Y et al (2013) Manipulation of the porcine epidemic diarrhea virus genome using targeted RNA recombination. PLoS ONE 8(8):e69997","journal-title":"PLoS ONE"},{"issue":"Pt 6","key":"2249_CR23","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1099\/0022-1317-82-6-1273","volume":"82","author":"V Thiel","year":"2001","unstructured":"Thiel V, Herold J, Schelle B et al (2001) Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J Gen Virol 82(Pt 6):1273\u20131281","journal-title":"J Gen Virol"},{"key":"2249_CR24","doi-asserted-by":"publisher","first-page":"1627509","DOI":"10.3389\/fmicb.2025.1627509","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, Zhu J, Zhang D et al (2025) Development of a yeast-based CRISPR genome editing system for feline coronavirus. Front Microbiol 16:1627509","journal-title":"Front Microbiol"},{"issue":"3","key":"2249_CR25","doi-asserted-by":"publisher","first-page":"109014","DOI":"10.1016\/j.celrep.2021.109014","volume":"35","author":"S Torii","year":"2021","unstructured":"Torii S, Ono C, Suzuki R et al (2021) Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction. Cell Rep 35(3):109014","journal-title":"Cell Rep"},{"issue":"4","key":"2249_CR26","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1128\/JVI.03162-12","volume":"87","author":"J Edmonds","year":"2013","unstructured":"Edmonds J, Van Grinsven E, Prow N et al (2013) A novel bacterium-free method for generation of flavivirus infectious DNA by circular polymerase extension reaction allows accurate recapitulation of viral heterogeneity. J Virol 87(4):2367\u20132372","journal-title":"J Virol"},{"issue":"2","key":"2249_CR27","doi-asserted-by":"publisher","first-page":"e2411023","DOI":"10.71150\/jm.2411023","volume":"63","author":"CJ Park","year":"2025","unstructured":"Park CJ, Kim T, Yoo SM et al (2025) Efficiency of reverse genetics methods for rescuing Severe Acute Respiratory Syndrome Coronavirus 2. J Microbiol 63(2):e2411023","journal-title":"J Microbiol"},{"issue":"4","key":"2249_CR28","doi-asserted-by":"publisher","first-page":"e0269224","DOI":"10.1128\/spectrum.02692-24","volume":"13","author":"I Kida","year":"2025","unstructured":"Kida I, Tamura T, Kuroda Y et al (2025) Application of versatile reverse genetics system for feline coronavirus. Microbiol Spectr 13(4):e0269224","journal-title":"Microbiol Spectr"},{"issue":"5","key":"2249_CR29","doi-asserted-by":"publisher","first-page":"e53820","DOI":"10.15252\/embr.202153820","volume":"23","author":"J M\u00e9lade","year":"2022","unstructured":"M\u00e9lade J, Piorkowski G, Touret F et al (2022) A simple reverse genetics method to generate recombinant coronaviruses. EMBO Rep 23(5):e53820","journal-title":"EMBO Rep"},{"issue":"Pt 11","key":"2249_CR30","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1099\/vir.0.068023-0","volume":"95","author":"F Aubry","year":"2014","unstructured":"Aubry F, Nougair\u00e8de A, De Fabritus L et al (2014) Single-stranded positive-sense RNA viruses generated in days using infectious subgenomic amplicons. J Gen Virol 95(Pt 11):2462\u20132467","journal-title":"J Gen Virol"},{"issue":"8","key":"2249_CR31","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1099\/vir.0.000184","volume":"96","author":"J Jengarn","year":"2015","unstructured":"Jengarn J, Wongthida P, Wanasen N et al (2015) Genetic manipulation of porcine epidemic diarrhoea virus recovered from a full-length infectious cDNA clone. J Gen Virol 96(8):2206\u20132218","journal-title":"J Gen Virol"},{"issue":"1","key":"2249_CR32","doi-asserted-by":"publisher","first-page":"e01451-15","DOI":"10.1128\/mBio.01451-15","volume":"7","author":"A Beall","year":"2016","unstructured":"Beall A, Yount B, Lin CM et al (2016) Characterization of a pathogenic full-length cDNA clone and transmission model for porcine epidemic diarrhea virus strain PC22A. MBio 7(1):e01451-15","journal-title":"MBio"},{"issue":"2","key":"2249_CR33","doi-asserted-by":"publisher","first-page":"e3001091","DOI":"10.1371\/journal.pbio.3001091","volume":"19","author":"SJ Rihn","year":"2021","unstructured":"Rihn SJ, Merits A, Bakshi S et al (2021) A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research. PLoS Biol 19(2):e3001091","journal-title":"PLoS Biol"},{"issue":"1","key":"2249_CR34","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.1038\/s41467-021-23779-5","volume":"12","author":"AA Amarilla","year":"2021","unstructured":"Amarilla AA, Sng JDJ, Parry R et al (2021) A versatile reverse genetics platform for SARS-CoV-2 and other positive-strand RNA viruses. Nat Commun 12(1):3431","journal-title":"Nat Commun"},{"issue":"2","key":"2249_CR35","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1051\/vetres:2006055","volume":"38","author":"D Cavanagh","year":"2007","unstructured":"Cavanagh D (2007) Coronavirus avian infectious bronchitis virus. Vet Res 38(2):281\u2013297","journal-title":"Vet Res"},{"issue":"2","key":"2249_CR36","doi-asserted-by":"publisher","first-page":"e00064","DOI":"10.1128\/mBio.00064-15","volume":"6","author":"Y Ma","year":"2015","unstructured":"Ma Y, Zhang Y, Liang X et al (2015) Origin, evolution, and virulence of porcine deltacoronaviruses in the United States. MBio 6(2):e00064","journal-title":"MBio"},{"issue":"15","key":"2249_CR37","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1016\/j.vaccine.2020.01.001","volume":"38","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Cheng X, Zhao X et al (2020) Recombinant infectious bronchitis coronavirus H120 with the spike protein S1 gene of the nephropathogenic IBYZ strain remains attenuated but induces protective immunity. Vaccin 38(15):3157\u20133168","journal-title":"Vaccin"},{"issue":"4","key":"2249_CR38","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1111\/tbed.13862","volume":"68","author":"X Zhou","year":"2021","unstructured":"Zhou X, Zhou L, Zhang P et al (2021) A strain of porcine deltacoronavirus: genomic characterization, pathogenicity and its full-length cDNA infectious clone. Transbound Emerg Dis 68(4):2130\u20132146","journal-title":"Transbound Emerg Dis"},{"key":"2249_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00712-18","author":"P Fang","year":"2018","unstructured":"Fang P, Fang L, Ren J et al (2018) Porcine deltacoronavirus accessory protein NS6 antagonizes interferon beta production by interfering with the binding of RIG-I\/MDA5 to double-stranded RNA. J Virol. https:\/\/doi.org\/10.1128\/JVI.00712-18","journal-title":"J Virol"},{"issue":"1","key":"2249_CR40","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.1038\/s41467-020-17665-9","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei X, Dong X, Ma R et al (2020) Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun 11(1):3810","journal-title":"Nat Commun"},{"issue":"2","key":"2249_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1128\/JVI.01782-06","volume":"81","author":"SA Kopecky-Bromberg","year":"2007","unstructured":"Kopecky-Bromberg SA, Mart\u00ednez-Sobrido L, Frieman M et al (2007) Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists. J Virol 81(2):548\u2013557","journal-title":"J Virol"},{"key":"2249_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virusres.2014.07.024","volume":"194","author":"ML Dediego","year":"2014","unstructured":"Dediego ML, Nieto-Torres JL, Jimenez-Guarde\u00f1o JM et al (2014) Coronavirus virulence genes with main focus on SARS-CoV envelope gene. Virus Res 194:124\u2013137","journal-title":"Virus Res"},{"key":"2249_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/v14112319","author":"G Jang","year":"2022","unstructured":"Jang G, Lee D, Lee C (2022) Development of a next-generation vaccine platform for porcine epidemic diarrhea virus using a reverse genetics system. Viruses. https:\/\/doi.org\/10.3390\/v14112319","journal-title":"Viruses"},{"issue":"1","key":"2249_CR44","doi-asserted-by":"publisher","first-page":"6060","DOI":"10.1038\/s41467-022-33878-6","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang X, Liu J et al (2022) Publisher correction: a live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. Nat Commun 13(1):6060","journal-title":"Nat Commun"},{"issue":"5","key":"2249_CR45","doi-asserted-by":"publisher","first-page":"e00650-13","DOI":"10.1128\/mBio.00650-13","volume":"4","author":"F Almaz\u00e1n","year":"2013","unstructured":"Almaz\u00e1n F, Dediego ML, Sola I et al (2013) Engineering a replication-competent, propagation-defective middle east respiratory syndrome coronavirus as a vaccine candidate. MBio 4(5):e00650-13","journal-title":"MBio"},{"issue":"7","key":"2249_CR46","doi-asserted-by":"publisher","first-page":"e0045125","DOI":"10.1128\/jvi.00451-25","volume":"99","author":"M Liu","year":"2025","unstructured":"Liu M, Aryal B, Niu X et al (2025) Engineering a recombination-resistant live attenuated vaccine candidate with suppressed interferon antagonists for PEDV. J Virol 99(7):e0045125","journal-title":"J Virol"},{"issue":"4","key":"2249_CR47","doi-asserted-by":"publisher","first-page":"e0166324","DOI":"10.1128\/jvi.01663-24","volume":"99","author":"S Keep","year":"2025","unstructured":"Keep S, Foldes K, Dowgier G et al (2025) Recombinant infectious bronchitis virus containing mutations in non-structural proteins 10, 14, 15, and 16 and within the macrodomain provides complete protection against homologous challenge. J Virol 99(4):e0166324","journal-title":"J Virol"},{"key":"2249_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01246-20","author":"NS Ogando","year":"2020","unstructured":"Ogando NS, Zevenhoven-Dobbe JC, Van Der Meer Y et al (2020) The enzymatic activity of the nsp14 exoribonuclease is critical for replication of MERS-CoV and SARS-CoV-2. J Virol. https:\/\/doi.org\/10.1128\/JVI.01246-20","journal-title":"J Virol"},{"issue":"3","key":"2249_CR49","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","volume":"39","author":"FK Yoshimoto","year":"2020","unstructured":"Yoshimoto FK (2020) The proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19. Protein J 39(3):198\u2013216","journal-title":"Protein J"},{"issue":"5","key":"2249_CR50","doi-asserted-by":"publisher","first-page":"e1000896","DOI":"10.1371\/journal.ppat.1000896","volume":"6","author":"LD Eckerle","year":"2010","unstructured":"Eckerle LD, Becker MM, Halpin RA et al (2010) Infidelity of SARS-CoV Nsp14-exonuclease mutant virus replication is revealed by complete genome sequencing. PLoS Pathog 6(5):e1000896","journal-title":"PLoS Pathog"},{"issue":"12","key":"2249_CR51","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1038\/nm.2972","volume":"18","author":"RL Graham","year":"2012","unstructured":"Graham RL, Becker MM, Eckerle LD et al (2012) A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal disease. Nat Med 18(12):1820\u20131826","journal-title":"Nat Med"},{"key":"2249_CR52","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1146\/annurev-biochem-052521-115653","volume":"91","author":"Z Lou","year":"2022","unstructured":"Lou Z, Rao Z (2022) The life of SARS-CoV-2 inside cells: replication-transcription complex assembly and function. Annu Rev Biochem 91:381\u2013401","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"2249_CR53","doi-asserted-by":"publisher","first-page":"109493","DOI":"10.1016\/j.celrep.2021.109493","volume":"36","author":"J Trimpert","year":"2021","unstructured":"Trimpert J, Dietert K, Firsching TC et al (2021) Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding. Cell Rep 36(5):109493","journal-title":"Cell Rep"},{"issue":"8","key":"2249_CR54","doi-asserted-by":"publisher","first-page":"17088","DOI":"10.1038\/nmicrobiol.2017.88","volume":"2","author":"G Moratorio","year":"2017","unstructured":"Moratorio G, Henningsson R, Barbezange C et al (2017) Attenuation of RNA viruses by redirecting their evolution in sequence space. Nat Microbiol 2(8):17088","journal-title":"Nat Microbiol"},{"issue":"8","key":"2249_CR55","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/s41564-024-01755-1","volume":"9","author":"J Sch\u00f6n","year":"2024","unstructured":"Sch\u00f6n J, Barut GT, Tr\u00fceb BS et al (2024) A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications. Nat Microbiol 9(8):2099\u20132112","journal-title":"Nat Microbiol"},{"key":"2249_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/v14081746","author":"W Li","year":"2022","unstructured":"Li W, Lei M, Li Z et al (2022) Development of a genetically engineered bivalent vaccine against porcine epidemic diarrhea virus and porcine rotavirus. Viruses. https:\/\/doi.org\/10.3390\/v14081746","journal-title":"Viruses"},{"key":"2249_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/v11080682","author":"A Pascual-Iglesias","year":"2019","unstructured":"Pascual-Iglesias A, Sanchez CM, Penzes Z et al (2019) Recombinant chimeric transmissible gastroenteritis virus (TGEV)-porcine epidemic diarrhea virus (PEDV) virus provides protection against virulent PEDV. Viruses. https:\/\/doi.org\/10.3390\/v11080682","journal-title":"Viruses"},{"key":"2249_CR58","doi-asserted-by":"publisher","first-page":"1633661","DOI":"10.3389\/fimmu.2025.1633661","volume":"16","author":"X Yan","year":"2025","unstructured":"Yan X, Zhang X, Lyu X et al (2025) Recombinant SADS-CoV as a vector for porcine epidemic diarrhea vaccine development. Front Immunol 16:1633661","journal-title":"Front Immunol"},{"issue":"2","key":"2249_CR59","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1079\/AHR200479","volume":"5","author":"J Pasick","year":"2004","unstructured":"Pasick J (2004) Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication. Anim Health Res Rev 5(2):257\u2013262","journal-title":"Anim Health Res Rev"},{"key":"2249_CR60","first-page":"185","volume":"114","author":"G Floegel-Niesmann","year":"2003","unstructured":"Floegel-Niesmann G (2003) Marker vaccines and companion diagnostic tests for classical swine fever. Dev Biol (Basel) 114:185\u2013191","journal-title":"Dev Biol (Basel)"},{"issue":"10","key":"2249_CR61","doi-asserted-by":"publisher","first-page":"e1005215","DOI":"10.1371\/journal.ppat.1005215","volume":"11","author":"JM Jimenez-Guarde\u00f1o","year":"2015","unstructured":"Jimenez-Guarde\u00f1o JM, Regla-Nava JA, Nieto-Torres JL et al (2015) Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine. PLoS Pathog 11(10):e1005215","journal-title":"PLoS Pathog"},{"issue":"3","key":"2249_CR62","doi-asserted-by":"publisher","first-page":"E386","DOI":"10.1073\/pnas.1619242114","volume":"114","author":"C Le Nou\u00ebn","year":"2017","unstructured":"Le Nou\u00ebn C, Mccarty T, Brown M et al (2017) Genetic stability of genome-scale deoptimized RNA virus vaccine candidates under selective pressure. Proc Natl Acad Sci U S A 114(3):E386\u2013E395","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"2249_CR63","doi-asserted-by":"publisher","first-page":"e01193","DOI":"10.1128\/jvi.01193-23","volume":"97","author":"X Niu","year":"2023","unstructured":"Niu X, Liu M, Yang S et al (2023) A recombination-resistant genome for live attenuated and stable PEDV vaccines by engineering the transcriptional regulatory sequences. J Virol 97(12):e01193\u2013e01223","journal-title":"J Virol"},{"issue":"10","key":"2249_CR64","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","volume":"5","author":"WS Lee","year":"2020","unstructured":"Lee WS, Wheatley AK, Kent SJ et al (2020) Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol 5(10):1185\u20131191","journal-title":"Nat Microbiol"},{"key":"2249_CR65","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.3389\/fmicb.2018.02991","volume":"9","author":"MK Smatti","year":"2018","unstructured":"Smatti MK, Al Thani AA, Yassine HM (2018) Viral-induced enhanced disease illness. Front Microbiol 9:2991","journal-title":"Front Microbiol"},{"key":"2249_CR66","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines13040425","author":"X Peng","year":"2025","unstructured":"Peng X, Han Y, Xue S et al (2025) Low antibody-dependent enhancement of viral entry activity supports the safety of inactivated SARS-CoV-2 vaccines. Vaccines. https:\/\/doi.org\/10.3390\/vaccines13040425","journal-title":"Vaccines"},{"key":"2249_CR67","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11071240","author":"J Sawant","year":"2023","unstructured":"Sawant J, Patil A, Kurle S (2023) A review: understanding molecular mechanisms of antibody-dependent enhancement in viral infections. Vaccines. https:\/\/doi.org\/10.3390\/vaccines11071240","journal-title":"Vaccines"},{"issue":"4","key":"2249_CR68","doi-asserted-by":"publisher","first-page":"e35421","DOI":"10.1371\/journal.pone.0035421","volume":"7","author":"CT Tseng","year":"2012","unstructured":"Tseng CT, Sbrana E, Iwata-Yoshikawa N et al (2012) Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus. PLoS ONE 7(4):e35421","journal-title":"PLoS ONE"},{"key":"2249_CR69","doi-asserted-by":"publisher","first-page":"882856","DOI":"10.3389\/fimmu.2022.882856","volume":"13","author":"N Luan","year":"2022","unstructured":"Luan N, Li T, Wang Y et al (2022) Th2-oriented immune serum after SARS-CoV-2 vaccination does not enhance infection in vitro. Front Immunol 13:882856","journal-title":"Front Immunol"},{"issue":"6","key":"2249_CR70","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1128\/JVI.02980-14","volume":"89","author":"Y Honda-Okubo","year":"2015","unstructured":"Honda-Okubo Y, Barnard D, Ong CH et al (2015) Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. J Virol 89(6):2995\u20133007","journal-title":"J Virol"},{"issue":"3","key":"2249_CR71","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","volume":"19","author":"P V\u2019kovski","year":"2021","unstructured":"V\u2019kovski P, Kratzel A, Steiner S et al (2021) Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol 19(3):155\u2013170","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"2249_CR72","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1620\/tjem.250.271","volume":"250","author":"S Baloch","year":"2020","unstructured":"Baloch S, Baloch MA, Zheng T et al (2020) The Coronavirus disease 2019 (COVID-19) pandemic. Tohoku J Exp Med 250(4):271\u2013278","journal-title":"Tohoku J Exp Med"},{"key":"2249_CR73","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.coviro.2018.12.001","volume":"34","author":"Q Wang","year":"2019","unstructured":"Wang Q, Vlasova AN, Kenney SP et al (2019) Emerging and re-emerging coronaviruses in pigs. Curr Opin Virol 34:39\u201349","journal-title":"Curr Opin Virol"},{"issue":"5","key":"2249_CR74","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s12250-021-00364-0","volume":"36","author":"H Turlewicz-Podbielska","year":"2021","unstructured":"Turlewicz-Podbielska H, Pomorska-M\u00f3l M (2021) Porcine coronaviruses: overview of the state of the art. Virol Sin 36(5):833\u2013851","journal-title":"Virol Sin"},{"key":"2249_CR75","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3389\/fvets.2019.00053","volume":"6","author":"JC Mora-D\u00edaz","year":"2019","unstructured":"Mora-D\u00edaz JC, Pi\u00f1eyro PE, Houston E et al (2019) Porcine hemagglutinating encephalomyelitis virus: a review. Front Vet Sci 6:53","journal-title":"Front Vet Sci"},{"key":"2249_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/v12091023","author":"C Haake","year":"2020","unstructured":"Haake C, Cook S, Pusterla N et al (2020) Coronavirus infections in companion animals: virology, epidemiology, clinical and pathologic features. Viruses. https:\/\/doi.org\/10.3390\/v12091023","journal-title":"Viruses"},{"issue":"4","key":"2249_CR77","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/jmv.25685","volume":"92","author":"G Li","year":"2020","unstructured":"Li G, Fan Y, Lai Y et al (2020) Coronavirus infections and immune responses. J Med Virol 92(4):424\u2013432","journal-title":"J Med Virol"},{"issue":"4","key":"2249_CR78","doi-asserted-by":"publisher","first-page":"e3003115","DOI":"10.1371\/journal.pbio.3003115","volume":"23","author":"HC Kubinski","year":"2025","unstructured":"Kubinski HC, Despres HW, Johnson BA et al (2025) Variant mutation G215C in SARS-CoV-2 nucleocapsid enhances viral infection via altered genomic encapsidation. PLoS Biol 23(4):e3003115","journal-title":"PLoS Biol"},{"issue":"7","key":"2249_CR79","doi-asserted-by":"publisher","first-page":"e0046725","DOI":"10.1128\/jvi.00467-25","volume":"99","author":"AL Morgan","year":"2025","unstructured":"Morgan AL, Vu MN, Zhou Y et al (2025) The furin cleavage site is required for pathogenesis, but not transmission, of SARS-CoV-2. J Virol 99(7):e0046725","journal-title":"J Virol"},{"issue":"6","key":"2249_CR80","first-page":"112451","volume":"28","author":"M Afzal","year":"2025","unstructured":"Afzal M, Melnyk D, Courty T et al (2025) Determination of resilience of a panel of broadly neutralizing mAbs to emerging variants of SARS-CoV-2 generated using reverse genetics. iSci 28(6):112451","journal-title":"iSci"},{"issue":"8","key":"2249_CR81","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/S1473-3099(22)00422-4","volume":"22","author":"P Arora","year":"2022","unstructured":"Arora P, Kempf A, Nehlmeier I et al (2022) Augmented neutralisation resistance of emerging omicron subvariants BA.2.12.1, BA.4, and BA.5. Lancet Infect Dis 22(8):1117\u20131118","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"2249_CR82","doi-asserted-by":"publisher","first-page":"2412643","DOI":"10.1080\/22221751.2024.2412643","volume":"13","author":"LV Pham","year":"2024","unstructured":"Pham LV, Underwood AP, Binderup A et al (2024) Neutralisation resistance of SARS-CoV-2 spike-variants is primarily mediated by synergistic receptor binding domain substitutions. Emerg Microbes Infect 13(1):2412643","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"2249_CR83","doi-asserted-by":"publisher","first-page":"e1009439","DOI":"10.1371\/journal.ppat.1009439","volume":"17","author":"X Ju","year":"2021","unstructured":"Ju X, Zhu Y, Wang Y et al (2021) A novel cell culture system modeling the SARS-CoV-2 life cycle. PLoS Pathog 17(3):e1009439","journal-title":"PLoS Pathog"},{"issue":"5583","key":"2249_CR84","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1126\/science.1072266","volume":"297","author":"J Cello","year":"2002","unstructured":"Cello J, Paul AV, Wimmer E (2002) Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science 297(5583):1016\u20131018","journal-title":"Science"},{"key":"2249_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-09155-z","author":"MA Tortorici","year":"2025","unstructured":"Tortorici MA, Choi A, Gibson CA et al (2025) Loss of FCoV-23 spike domain 0 enhances fusogenicity and entry kinetics. Nat. https:\/\/doi.org\/10.1038\/s41586-025-09155-z","journal-title":"Nat"},{"issue":"1","key":"2249_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14760584.2025.2538561","volume":"24","author":"Q He","year":"2025","unstructured":"He Q, Zhang Y, Fu Z et al (2025) Broad-spectrum coronavirus vaccines: integrated strategies to combat viral diversity. Expert Rev Vaccines 24(1):1\u201312","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"2249_CR87","doi-asserted-by":"publisher","first-page":"8495","DOI":"10.1038\/s41467-025-63399-x","volume":"16","author":"C Whittaker","year":"2025","unstructured":"Whittaker C, Barnsley G, Mesa DO et al (2025) Quantifying the impact of a broadly protective sarbecovirus vaccine in a future SARS-X pandemic. Nat Commun 16(1):8495","journal-title":"Nat Commun"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02249-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-026-02249-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-026-02249-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T16:02:11Z","timestamp":1786464131000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-026-02249-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["2249"],"URL":"https:\/\/doi.org\/10.1007\/s11262-026-02249-4","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"28 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}